According to a recent LinkedIn post from OpenEvidence, the company is introducing a product called Coding Intelligence to address complexity in medical billing workflows. The post describes the tool as automating code selection so physicians can stay focused on patient care while still supporting accurate and timely reimbursement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights features including automatic ICD-10 diagnoses, E/M level recommendations with supporting medical decision-making rationale, and CPT code suggestions derived from clinical documentation and current guidelines. The post indicates that Coding Intelligence is applied at the end of each visit and becomes available as soon as the clinical note is completed.
For investors, the post suggests OpenEvidence is moving deeper into high-value revenue-cycle functions, which could enhance its monetization potential with provider organizations facing billing complexity and staffing constraints. If the product proves effective at improving reimbursement speed and accuracy, it may strengthen OpenEvidence’s competitive position in clinical documentation and coding automation relative to other healthcare IT and AI vendors.
The emphasis on automation at the point of care implies a strategy aimed at embedding the product into everyday clinical workflows, which could support higher customer stickiness and recurring revenue. However, the financial impact will depend on adoption rates among physicians, integration with existing electronic health record systems, and demonstrated return on investment for health systems and practices.

